Turkish Journal of Biology
Volume 38

Number 3

Article 11

1-1-2014

Hepatoprotective effects of Malva sylvestris L. against
paracetamol-induced hepatotoxicity
LIAQAT HUSSAIN
JAVARIA IKRAM
KANWAL REHMAN
MUHAMMAD TARIQ
MUHAMMAD IBRAHIM

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
HUSSAIN, LIAQAT; IKRAM, JAVARIA; REHMAN, KANWAL; TARIQ, MUHAMMAD; IBRAHIM, MUHAMMAD;
and AKASH, MUHAMMAD SAJID HAMID (2014) "Hepatoprotective effects of Malva sylvestris L. against
paracetamol-induced hepatotoxicity," Turkish Journal of Biology: Vol. 38: No. 3, Article 11. https://doi.org/
10.3906/biy-1312-32
Available at: https://journals.tubitak.gov.tr/biology/vol38/iss3/11

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced
hepatotoxicity
Authors
LIAQAT HUSSAIN, JAVARIA IKRAM, KANWAL REHMAN, MUHAMMAD TARIQ, MUHAMMAD IBRAHIM, and
MUHAMMAD SAJID HAMID AKASH

This article is available in Turkish Journal of Biology: https://journals.tubitak.gov.tr/biology/vol38/iss3/11

Turkish Journal of Biology

Turk J Biol
(2014) 38: 396-402
© TÜBİTAK
doi:10.3906/biy-1312-32

http://journals.tubitak.gov.tr/biology/

Research Article

Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced hepatotoxicity
1

1

2

2

Liaqat HUSSAIN , Javaria IKRAM , Kanwal REHMAN , Muhammad TARIQ ,
3
1,2,
Muhammad IBRAHIM , Muhammad Sajid Hamid AKASH *
1
College of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan
2
Institute of Pharmacology, Toxicology, and Biochemical Pharmaceutics,
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China
3
Department of Applied Chemistry, Faculty of Science and Technology,
Government College University Faisalabad, Faisalabad, Pakistan
Received: 10.12.2013

Accepted: 12.02.2014

Published Online: 14.04.2014

Printed: 12.05.2014

Abstract: Malva sylvestris is traditionally used for the treatment of liver diseases, but sufficient pharmacological-based scientific literature
is not available online to authenticate its use in liver ailments. We aimed to assess the hepatoprotective effects of Malva sylvestris against
paracetamol-induced hepatotoxicity in mice. The extract was concentrated using a rotary evaporator and then desired concentrations of
extracts were made by dissolving in normal saline. The standard drug silymarin (100 mg/kg) was used as a reference drug to compare the
therapeutic effects of Malva sylvestris. Two different doses of Malva sylvestris (300 and 600 mg/kg) were administered intraperitoneally
for 7 consecutive days followed by intraperitoneal administration of paracetamol (250 mg/kg). Paracetamol significantly induced
oxidative stress in the liver, ultimately leading to increased serum levels of liver enzyme markers like alanine aminotransferase, aspartate
aminotransferase, alkaline phosphatase, total bilirubin, and direct bilirubin. The extract of Malva sylvestris significantly reduced the
serum levels of these elevated liver enzyme markers in a dose-dependent manner. Histopathological examination of liver tissues
also showed hepatoprotective effects of Malva sylvestris in restoring normal functional ability of the liver. The results of our study
strongly suggest that the extract of Malva sylvestris has strong hepatoprotective effects against paracetamol-induced liver injury, thereby
scientifically affirming its traditional therapeutic role in liver injury.
Key words: Hepatotoxicity, Malva sylvestris, paracetamol, silymarin, liver enzyme markers

1. Introduction
The liver, being the center of metabolic functions, plays
a crucial role in metabolizing a variety of xenobiotics;
it is therefore more vulnerable to the toxicity of these
chemicals. Hepatotoxicity, either dose-related or
idiosyncratic, is considered as a global health concern
and may occur as a result of drug metabolism. Because
of the lack of effective treatment options, liver diseases
have extremely poor prognosis and high mortality. Even
though various advancements have been achieved in the
field of modern medicine, liver diseases still remain a
major health issue. In view of that, investigations of new
therapeutic approaches are still ongoing (Choi et al., 2011;
Rehman et al., 2014). One of the most typical examples of
dose-related toxicity is that of paracetamol (James et al.,
2003). Paracetamol is most commonly used as an analgesic
and antipyretic. It is considered safe in its therapeutic
doses, but overdose toxicity of paracetamol is one of
the most common among the pharmaceutical product
* Correspondence: sajidakash@gmail.com
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poisonings that may cause liver injury. It is one of the
leading causes of hepatic failure worldwide and it exerts
hepatotoxic effects in a dose-dependent manner (Kelava
et al., 2010; El-Agamy et al., 2014). Normally, paracetamol
is metabolized by cytochrome P450 enzymes into an
active intermediate, i.e. N-acetyl-p-benzoquinone imine
(NAPQI), which is rapidly detoxified by conjugation with
glutathione (McGill et al., 2012). Excessive production
of NAPQI due to overdoses of paracetamol reduces the
levels of free glutathione by saturating the glucuronidation
and sulfation pathways, which ultimately leads to hepatic
necrosis progressing to liver malfunction. Excess NAPQI
binds to the mitochondrial proteins and also damages
the mitochondria in hepatocytes, leading to extreme
generation of free radicals followed by lipid peroxidation
and finally hepatic cell death (McGill et al., 2012).
As the liver is actively involved in a variety of drug
metabolism, protection of the liver from the deleterious
effects of drug metabolites is of utmost importance. To
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treat such situations, various synthetic drugs have been
developed, but most of them have numerous other side
effects. From ancient times, man has always used herbs
for various liver disorders as a treatment strategy, because
natural remedies from traditional medicinal plants have
proven to be effective alternative treatments in cases
of liver injury. From various studies, it has been found
that hepatoprotective effects are directly associated with
phytoconstituents (Sabir and Rocha, 2008; Choi et al.,
2009; Bhaskar and Balakrishnan, 2010; Huang et al., 2010;
Nayak et al., 2011; Rehman et al., 2012; Ibrahim et al.,
2013). All around the world, and especially in developing
countries, people use traditional herbal medicines;
therefore, there is a strong need to develop such a
hepatoprotective medicine using natural products that can
pass the safety evaluation and screening in the early phase
of drug discovery because most toxic compounds are
metabolized in the liver (Iwalokun et al., 2006; Adeneye,
2009; Ajiboye et al., 2010; Ahmed et al., 2013; Chanda
et al., 2013). Hence, the present study is focused on the
evaluation of hepatoprotective effects of Malva sylvestris
on paracetamol-induced hepatotoxicity.
Malva sylvestris L. belongs to the family Malvaceae.
It is commonly known as common mellow in Europe,
gulkhaira or vilayatti kangani in Pakistan and India
(Mustafa and Ali, 2011), khabazi or tole in Iran, malva
in Portugal, marva in Italy, and ebegümeci in Turkey
(Tabaraki et al., 2012). Although it is found all around the
world as a weed, its native regions are South Europe, North
Africa, and Southwest Asia. The plant preferably grows
in damp places like near oceans, marshes, ditches, river
banks, and meadows (Razavi et al., 2011). It is an annual
or perennial herb, reaching a height of almost 1 m. Leaves
are almost heart-shaped with 5–7 lobes and flowers are
bright pink with purple veins (Figure 1). Malva sylvestris
is rich in phytoconstituents (Nehir and Karakaya, 2004;
Wang, 2005; Barros et al., 2010; Çadırcı et al., 2012; Sabri
et al., 2012; Tabaraki et al., 2012). It has shown potential
therapeutic effects against various diseases (Jan et al., 2009;
Pirbalouti et al., 2009; Marouane et al., 2011; Razavi et al.,
2011). Diabetes mellitus, being an autoimmune syndrome,
is among the major life-threatening diseases (Akash et
al., 2012, 2013a, 2013b). Synthetic antidiabetic agents are
unable to cure diabetes due to their potential side effects
(Akash et al., 2012). There are varieties of plants that have
the potential to cure diabetes mellitus (Romila et al., 2010;
Ponnusamy et al., 2011; Akash et al., 2011, 2013c; Patel et
al., 2012; Rahman et al., 2012; Arif et al., 2014). Recently, it
has also been reported that the extract of Malva sylvestris
has wound-healing potential in alloxan-induced diabetic
rats (Pirbalouti et al., 2010, 2012). The extract of Malva
sylvestris also has antiinflammatory and antiulcerogenic
properties (Conforti et al., 2008; Sleiman and Daher, 2009;

Figure 1. Malva sylvestris.

Pirbalouti et al., 2010; Gasparetto et al., 2012; Prudente et
al., 2013).
Being a potential antioxidant agent, Malva sylvestris
may also have hepatoprotective activity; however, so far, no
scientific data have been made available in the literature.
The present study aimed to evaluate the hepatoprotective
activity of the methanolic extract of Malva sylvestris L. in
Swiss albino mice intoxicated with paracetamol in a dosedependent manner.
2. Materials and methods
2.1. Drugs and chemicals
Paracetamol was purchased from Glaxo Smith Kline Ltd.,
Karachi, Pakistan. Silymarin was purchased from Abbott
Laboratories, Karachi, Pakistan. Diagnostic kits were
purchased from Merck and DiaSys Diagnostic Systems,
Germany. All other chemicals and reagents used in this
study were of high analytical grade and were used without
further modifications.
2.2. Experimental animals
Healthy adult male Swiss albino mice (25–35 g) were
used in this study. The animals were obtained from the
animal house of the University of Agricultural Faisalabad,
Faisalabad, Pakistan. Animals were kept in standard
plastic mice cages with stainless steel coverlids in an airconditioned room maintained at 25 ± 2 °C with a regular
12 h light/12 h dark cycle and they were provided with
standard laboratory food. Free access to food and water
ad libitum was provided. All the procedures involving the
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animals were in accordance with the approved protocol of
the Ethics Committee on Animal Experimentation of the
Government College University Faisalabad, Faisalabad,
Pakistan.
2.3. Plant material and preparation of extract
Fresh Malva sylvestris L. (whole plant) was collected
from Rawalpindi District of Punjab Province, Pakistan.
The plant material was identified at Arid Agricultural
University, Rawalpindi, Pakistan, verified by a plant
taxonomist. The voucher specimen (voucher specimen
no. 2078) was deposited at Arid Agricultural University
for future reference. The whole plant was washed and airdried. The dried material was then pulverized separately
into fine powder by a mechanical grinder and stored in
airtight bottles. Dried powder (almost 2 kg) was soaked
in 6 L of 95% methanol and was kept on a shaker for 7
consecutive days. After that, the extracts were separated
by filtration and concentrated at 40 °C under reduced
pressure by rotary evaporator. The extract was stored in an
air-tight bottle at 4 °C for further experiments.
2.4. Experimental design
2.4.1. Animal groups
Mice were divided into 5 equal groups. Group I was the
control group, treated with normal saline; group II was
treated with paracetamol; group III was treated with
silymarin; group IV was treated with 300 mg/kg extract
of Malva sylvestris; and group V was treated with 600 mg/
kg extract of Malva sylvestris. Food was withdrawn 18–24
h before the experiment, although water was given ad
libitum.
Group I served as the normal control and received
only normal saline (1 mL/kg daily, intraperitoneally)
for 7 consecutive days, while group II received only
paracetamol (250 mg/kg, intraperitoneally, suspended
in normal saline) for 7 consecutive days. Group III
received the standard drug silymarin at 100 mg/kg daily,
intraperitoneally for 7 consecutive days, and received
paracetamol (250 mg/kg daily, intraperitoneally) 3 h after
the administration of silymarin. In groups IV and V, the
plant extract was administered intraperitoneally in 2
different doses, i.e. MS-300 (300 mg/kg) and MS-600 (600
mg/kg), daily for 7 days, and mice received paracetamol
(250 mg/kg, intraperitoneally) 3 h after the administration
of the extracts.
At the end of treatment, 24 h after the last dose
administration, mice were anesthetized with chloroform.
Blood samples of each animal were taken by cardiac
puncture using sterile disposable syringes and immediately
transferred into disposable glass tubes for estimation of
liver enzyme markers. Serum was obtained by centrifuging
blood samples at 2500 rpm for 15 min at 4 °C and stored at
–20 °C until further analysis.
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2.4.2. Measurement of serum levels of liver enzyme
markers and bilirubin
The collected serum was further analyzed for the
estimation of liver enzyme markers. Briefly, alanine
aminotransferase (ALT), alkaline phosphatase (ALP), and
aspartate aminotransferase (AST) contents in the serum
were estimated using commercially available kits (Merck
and DiaSys Diagnostic Systems) according to the standard
protocol. Total bilirubin and direct bilirubin contents in
the serum were estimated via commercially available kits
(Merck and DiaSys Diagnostic Systems) according to the
manufacturer’s instructions.
2.4.3. Histopathological examination of liver tissues
The liver tissues were dissected out and washed with icecold normal saline, and a small cross-section of the liver
was separated out. Small pieces were fixed with 10%
neutral-buffered formalin and embedded in paraffin.
Tissue processing was done by dehydrating with graded
ethanol (50%–100%) and clearing by xylene followed by
paraffin infiltration. Liver tissue sections were cut in sizes
of 4–5 µm, deparaffinized with xylene, and rehydrated
with graded isopropyl alcohol and a drop of water. Water
was removed and slides were oven-dried. After tissue
fixation, staining was done with hematoxylin and eosin.
The stained sections of slides were examined under highresolution microscope and photographs were taken.
2.5. Statistical analysis
The results are presented as mean ± SD. Statistical analysis
was performed using one-way analysis of variance
followed by the Tukey–Kramer multiple comparison test
using Graph Pad Prism 5 (Graph Pad Software Inc., USA).
P < 0.05 was considered statistically significant.
3. Results
3.1. Effect of Malva sylvestris on liver enzyme markers
Biochemical analysis of liver enzyme markers signified
that the use of paracetamol in high doses strikingly raised
the serum levels of liver enzyme markers ALT, AST,
and ALP as compared to the control group treated with
normal saline (Figure 2). Treatment with methanolic
extract of Malva sylvestris and standard drug silymarin
showed hepatoprotective activity against paracetamolinduced hepatotoxicity by maintaining the serum levels of
ALT, AST, and ALP at markedly reduced levels in a dosedependent manner (Figure 2).
We also measured the serum levels of total bilirubin
and direct bilirubin in all treated groups. The group treated
with paracetamol alone exhibited high levels of bilirubins
as compared to the control group (Figure 3). Treatment
with methanolic extract of Malva sylvestris at 2 different
doses decreased the serum levels of bilirubins more
significantly when directly compared with paracetamol-
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Figure 2. Estimation of ALT (A), AST (B), and ALP (C) in the serum of rats treated with normal saline, paracetamol, silymarin, MS300 (M. sylvestris, 300 mg/kg), and MS-600 (M. sylvestris, 600 mg/kg). Values are expressed as mean ± SD for 5 rats in each group.
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Figure 3. Estimation of total bilirubin (A) and direct bilirubin (B) in the serum of rats treated with
normal saline, paracetamol, silymarin, MS-300 (M. sylvestris, 300 mg/kg), and MS-600 (M. sylvestris,
600 mg/kg). Values are expressed as mean ± SD for 5 rats in each group. *: P < 0.05, the value of
experimental groups is significantly different from the control; #: P < 0.05, the value of experimental
groups is significantly different from the group treated with paracetamol.

treated mice. We also found a nonsignificant difference
between the silymarin-treated group and the group treated
with a high dose (600 mg/kg) of Malva sylvestris (Figure 3).
3.2. Histopathological examination of the liver
Histopathological analysis revealed that group I,
treated with normal saline, showed normal sections of

liver tissues (Figure 4A), whereas the liver sections of
paracetamol-treated mice lost their normal architecture.
Severe congestion of blood vessels along with hepatic cell
necrosis, vacuolization, eosinophils, macrophages, plasma
cells infiltration, degeneration of hepatocytes nuclei,
and fibrosis were seen (Figure 4B). Silymarin treatment
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Figure 4. Histopathological changes in the liver of control and treated animals. A- Control group with
no treatment. B- Paracetamol-treated group showing macrophages, plasma cell infiltration (black
arrows), vacuolization (white arrows), and cell necrosis (circles). C- Group treated with silymarin
followed by paracetamol showing binucleated cells with slight vacuolization and infiltration. DGroup treated with MS-300 followed by paracetamol. E- Group treated with MS-600 followed by
paracetamol. Figures A and E are 200× and B, C, and D are 100× magnification.

followed by paracetamol administration displayed
normal structure of hepatocytes, mild infiltration, and
vacuolization (Figure 4C). Treatment with Malva sylvestris
extract (MS-300) followed by paracetamol administration
showed few binucleated cells while most cells were normal,
with slight congestion, vacuolization, and infiltration
(Figure 4D). However, in the case of MS-600, the recovery
stage had well-arranged hepatocytes and no necrosis was
evident (Figure 4E).
4. Discussion
Medicinal plant-based medicines are potential sources
of naturally occurring phytoconstituents that may act in
a variety of ways to suppress the generation of reactive
oxygen species. These phytoconstituents have broad ranges
of pharmacological activities (Karaman et al., 2010; Orhan
et al., 2012; Zayova et al., 2013; Zia-Ul-Haq et al., 2013).
Glutathione is one of the major antioxidants that protect
the liver from toxic effects of paracetamol (Prescott, 2005),
but overdoses of paracetamol may result in the depletion
of glutathione stores, which ultimately leads to the release
of serum levels of liver enzyme biomarkers indicating
mitochondrial damage (McGill et al., 2012; da Rosa et al.,
2012). Paracetamol-induced hepatotoxicity results in the
elevated levels of liver enzyme markers such as ALT, AST,
and ALP. Elevated levels of these enzymes in the serum
represent the loss of functional integrity due to the cellular
leakage of these enzymes from the cell membrane of the
liver, which is reflected by the histopathological alterations
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(Ramaiah 2007; Sreelatha et al., 2009; Aseervatham et al.,
2014). Estimations of these liver enzyme markers in the
serum reflect the normal and/or abnormal condition of
the liver. Methanolic extract of Malva sylvestris maintained
the serum levels of ALT, AST, and ALP. In the present
study, we used 2 doses of Malva sylvestris (300 mg/kg
and 600 mg/kg). We found that Malva sylvestris showed
hepatoprotective effects in a dose-dependent manner.
A high dose of Malva sylvestris showed a nonsignificant
difference with the hepatoprotective effects of standard
drug silymarin (Figure 2).
Similarly, the elevated levels of bilirubin in serum are
also attributed to the paracetamol-induced hepatotoxicity,
which is usually due to the abnormal production of
bilirubin in the liver (Aseervatham et al., 2014). Bilirubin
level is also considered as one of the most important liver
function tests as it reflects the functional integrity of the
liver. In the present study, we measured the serum levels
of total bilirubin and direct bilirubin. The significant
reduction in the serum levels of these bilirubins in Malva
sylvestris-treated mice was observed in a dose-dependent
manner (Figure 3). The observed hepatoprotective effect
of Malva sylvestris in paracetamol-induced hepatotoxicity
might be due to the presence of an active concentration
of phytoconstituents that might restore the glutathione
levels in hepatocytes, due to which the functional integrity
of the liver was increased, as was evident from the
decreased levels of liver enzyme markers and improved
live histopathological examinations of liver.
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In conclusion, the results of the present study reveal that
the methanolic extract of Malva sylvestris can significantly
protect the liver from the damaging effects of paracetamol
in a dose-dependent manner by considerably decreasing the
serum levels of liver enzyme markers. The decreased serum
levels of these enzymes were further accompanied by the
improvement of liver histology in Malva sylvestris-treated
mice, which remarkably exhibited the hepatoprotective effects

of Malva sylvestris in paracetamol-induced hepatotoxicity.
The hepatoprotective effects of Malva sylvestris scientifically
validate the traditional use of Malva sylvestris in liver ailments.
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